FOS and neoplasm: As mentioned earlier, JDP2 was also found to be a regulator of JUND’s expression, promoting its activation (together with JUNB) to form inhibitory AP-1 complexes as opposed to tumor-promoting c-JUN-containing AP-1 [96] (Figure 3).